1st Circ. OKs Class Action Claim Against Biogen Over Statement Regarding Alzheimer’s Drug Dose-Response Relationship
The U.S. Court docket of Appeals for the First Circuit affirmed a decrease court docket’s dismissal of buyers’ securities fraud ...
Tag: DoseResponse
